Stay updated on Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 19 to 23, with specific new locations added in Connecticut, New York, Oregon, and Madrid. Additionally, the dates have been updated to reflect more recent timelines.SummaryDifference2%
- Check22 days agoChange DetectedThe page has been updated to include new drug treatments for pancreatic adenocarcinoma, while significant details about the study design and inclusion/exclusion criteria have been removed.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025. However, the removal of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of February 6, 2025, and revision version 2.14.2.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.